title: The use of blood transfusions and erythropoietin-stimulating agents in Swedish palliative care.
abstract: OBJECTIVE
  To outline the use of blood transfusions and erythropoietin-stimulating agents (ESAs) in palliative care in Sweden and to get an idea of whether or not these usually very sick patients benefit from the treatment.
  
  
  METHODS
  An internet-based questionnaire was sent out to 24 specialized palliative care units within the Swedish palliative research network. All data were registered by each member directly into a web-based survey generator from which the results were extracted and analyzed.
  
  
  RESULTS
  Twenty-two units registered 1,046 patients (median age 68 years, 87% had a cancer diagnosis). Among these patients, 900 were enrolled in advanced home care and the others were treated in in-patient units. Erythrocyte transfusions were given to 174 patients (17%) during the month before registration with a mean amount of 2.9 units (range 1-18) given to each patient. Erythrocyte transfusions were given to 18% of the patients with a malignancy and to 11% of the patients with a non-malignant disease. Six patients also received thrombocyte transfusions. One hundred seventeen patients (68%) were judged to benefit from the erythrocyte transfusions. Eighty-two (58%) of the 141 transfused patients enrolled in advanced home care received their transfusions in their homes. ESAs was given to 127 patients (12%).
  
  
  CONCLUSIONS
  Transfusions are not uncommon in Swedish palliative care. A majority seemed to benefit from the transfusions. Since they are expensive and time consuming, the effect should, however, be carefully evaluated in every individual in order to avoid ineffective treatment.
authors.affiliation: Department of Oncology, University Hospital, 751 85, Uppsala, Sweden. ulla.martinsson@akademiska.se
authors.forename: Ulla
authors.initials: U
authors.lastname: Martinsson
authors.forename: Staffan
authors.initials: S
authors.lastname: Lundström
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001803:Blood Transfusion; D002648:Child; D002675:Child, Preschool; D003430:Cross-Sectional Studies; D004921:Erythropoietin / Q000096:biosynthesis*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010166:Palliative Care; D013548:Sweden; D055815:Young Adult
chemical_list: D004921:Erythropoietin
references.citation: Transfus Clin Biol. 1996;3(4):235-9
references.pmid: 8983516
references.citation: J Pain Symptom Manage. 1996 Jul;12(1):18-22
references.pmid: 8718912
references.citation: Br J Haematol. 1989 Jan;71(1):131-6
references.pmid: 2492818
references.citation: Eur J Cancer. 2004 Oct;40(15):2293-306
references.pmid: 15454256
references.citation: Semin Oncol. 1998 Jun;25(3 Suppl 7):43-6
references.pmid: 9671330
references.citation: Eur J Cancer. 2004 Oct;40(15):2201-16
references.pmid: 15454245
references.citation: Ann Oncol. 2003 Apr;14(4):511-9
references.pmid: 12649095
references.citation: Palliat Med. 1995 Oct;9(4):307-13
references.pmid: 8548092
references.citation: Oncology. 2005;68 Suppl 1:3-11
references.pmid: 15855811
references.citation: Palliat Med. 2004 Mar;18(2):139
references.pmid: 15046411
references.citation: Clin Cancer Res. 2004 Oct 15;10(20):6855-64
references.pmid: 15501962
references.citation: Ann Oncol. 2004 May;15(5):839-40
references.pmid: 15111355
references.citation: Arch Pathol Lab Med. 2003 Mar;127(3):316-20
references.pmid: 12653575
references.citation: J Pain Symptom Manage. 1997 Jun;13(6):318
references.pmid: 9204650